PGY1/2 Pharmacotherapy
Purpose
PGY1 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for post-graduate year two (PGY2) residency training.
PGY2 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care of other advanced practice settings. Residents who successfully complete and accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized, along with board certification, if available.
Additional Program Description
The PGY1/2 Pharmacotherapy pharmacy residency program at the Medical University of South Carolina (MUSC) is a two-year postgraduate program which provides 24 months of training in a contemporary pharmacy practice setting. The residency program is intended to build upon pharmacotherapy knowledge and clinical skills to deliver specialized care across diverse inpatient and outpatient populations. A pharmacotherapy resident will provide direct patient care for pediatric, adult, and geriatric patient populations. The emphasis on various patient care populations is intended to improve confidence and allow for increased flexibility to transition between practice areas. Additionally, the residents will have various levels of involvement in longitudinal clinical research, department of pharmacy service projects, and the education of others.
Program Design
- Required Learning Experiences over a 24-month period:
- PGY1 Orientation (July, 1 month)
- PGY1 Project Month (December, 1 month)
- Acute Care (selective, 4 months*)
- Ambulatory Care (selective, 2 months*)
- Clinical Generalist (1 month)
- Critical Care (selective, 2 months*)
- Drug Information (1 month)
- Infectious Diseases (selective, 1 month*)
- Pediatrics (selective, 1 month*)
- Psychiatry (selective, 1 month*)
- Solid Organ Transplant (selective, 1 month*)
- Electives (8 months, customized to resident interest)
*Certain learning experiences are required but selective in that residents may select the specific learning experience under a more general topic
- Adult Inpatient On-Call Service (PGY2 only)
- Ambulatory Care Clinic (½ day twice per month PGY1 and ½ day weekly PGY2)
- Operational Evening Staffing (PGY1 only)
- Weekend Staffing (Average every 3rd weekend in 52-week period PGY1 and every 4th weekend PGY2)
- PGY1 & PGY2 Medication Use Evaluation (MUE)
- PGY1 & PGY2 Research Project
- PGY1 & PGY2 Seminar
- Research Certificate Program (Required)
- Two weekday evening staffing operational shifts (12:30 to 9 p.m.) in place of rotation twice monthly August through June (PGY1 only)
- Residents receive a project month during PGY1 year and can elect to use a project month during PGY2 or one project day per month
Residency Program Director
Allison Fabick, Pharm.D., MBA, BCCCP, BCPS
PGY1/2 Pharmacotherapy Residency Program Director
Clinical Pharmacy Specialist - Medical Surgical ICU (MSICU)
Education: MUSC College of Pharmacy
Post-graduate training: PGY1/2 Pharmacotherapy at MUSC Health
Rotations offered: Medical Surgical ICU (MSICU)
PGY1/2 Pharmacotherapy Resident
